Disrupting RTN4 (reticulon 4)-mediated ER remodeling may impair cancer pathogenicity in U2OS osteosarcoma cells by altering ER homeostasis and nuclear envelope assembly and disassembly during mitosis [31]. This evidence concerns the gene RTN4 and cancer.